Motion sickness clinical trial
The MRC Spatial Disorientation Group, Imperial
College School of Medicine, London ran a full clinical
trial with nevasic branded as TravelWell.
The trial proved conclusively that the programme is highly effective in combating the symptoms of nausea and vomiting associated with motion sickness.
The report from the trial is lodged with PubMed and available via the National Library of Medicine (USA).
Here is the abstract report:
1: J Travel Med. 2003 Mar-Apr,10(2):108-11 Behavioral methods of alleviating motion sickness: effectiveness of controlled breathing and a music audiotape.
Yen Pik Sang FD, Billar JP, Golding JF, Gresty MA.
The MRC Spatial Disorientation Group, Imperial College School of Medicine, London, United Kingdom.
BACKGROUND: Behavioral countermeasures for motion sickness would be advantageous because of the side effects of antiemetic drugs, but few alternatives treatments are available. The objective of this study was to compare the effectiveness of controlling breathing and listening to a music audiotape designed to reduce motion sickness symptoms, on increasing tolerance to motion sickness.
METHOD: Twenty-four healthy subjects were exposed to nauseogenic Coriolis stimulation on a rotating turntable under three conditions: whilst focusing on controlling breathing; listening to a music audiotape; or without intervention (control). The three conditions were performed by each subject according to a replicated factorial design at 1-week intervals at the same time of day. Ratings of motion sickness were obtained every 30 seconds. Once a level of mild nausea was reached subjects commenced controlling breathing or listened to the music audiotape. Motion was stopped after the onset of moderate nausea.
RESULTS: Mean (+/- SD) motion exposure time in minutes tolerated before the onset of moderate nausea was significantly longer (p <.01) for controlling breathing (10.7 +/- 5.6 min) and longer (p <.01) for music (10.4 +/- 5.6 min) compared with control (9.2 +/- 5.9 min).
CONCLUSIONS: Both controlling breathing and the music audiotape provided significant protection against motion sickness. They are easy to implement and free of side effects.
Publication Types: Clinical Trial
Controlled Clinical Trial
PMID: 12650654 [PubMed - indexed for MEDLINE]
Click the below line or copy and paste it to your address bar to view this information direct within the pages of PubMed (United States National Library Of Medicine: http://www.ncbi.nlm.nih.gov
The report was published by the International Society of Travel Medicine (http://www.istm.org/). To obtain the correct report quote "Journal of Travel Medicine Volume: 10 • Issue: 02 • 2003 • March • Page: 108"
NHS morning sickness study
Nevasic was studied by the UK NHS under the branded
name of MorningWell.
The study was commissioned by;
Mr M J Heard FRCOG
Department of Obstetrics and Gynaecology
Royal Hampshire County Hospital
Manager - Midwife Mrs Lynne Mayo - SRN, SCM, - Andover
NHS Birth Centre.
NHS research data.
NHS research data.
A National Health Service (NHS) Study showed 9 out of 10
pregnant women experienced a reduction or elimination of
their symptoms of nausea & vomiting in morning sickness
by using Nevasic branded as MorningWell.
Nevasic has been registered as a class 1 Medical Device in the UK
and the USA. It is also registered by the Australian
Medical Devices Listing Section (Conformity Assessment
Branch) as an exempt product under the Therapeutic Goods